Skip to main content

VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies

VERAXA’s Novel BiTAC Platform has the Potential to Deliver Multiple Next-Generation Solid Tumor Cancer Therapies, Including Novel Antibody-Drug Conjugate (“ADC”) and Bispecific T-cell Engager (“TCE”) Candidates, with Strong and Differentiated Clinical Profiles Company Pursuing Multiple Strategic Partnerships and Licensing Opportunities in 2025 and 2026 Transaction Values VERAXA at a Pre-money Equity Value of $1.3 Billion Actively Working with Existing and New VERAXA Investors to Raise a Crossover Financing Round, which is Expected to Close Ahead of the Business Combination, Alongside up to $253 Million in Cash Held in Trust Business Combination is Expected to be Completed in the Fourth Quarter of 2025 A Joint Investor Presentation Providing an Overview of the Proposed Transaction can be Viewed: https://dealroadshow.com/e/VER2025ZURICH,...

Continue reading

Update on Transaction Regulatory Approvals

BRISBANE, Australia, April 23, 2025 (GLOBE NEWSWIRE) — Sayona Mining Limited (“Sayona” or “Company”) (ASX:SYA; OTCQB:SYAXF) provides an update on the proposed transaction with Piedmont Lithium Inc. (“Piedmont Lithium”) (NASDAQ:PLL, ASX:PLL) (see announcement on 19 November 2024) (the “Transaction”) that will combine the two companies to create a leading lithium business. Subject to Sayona shareholder approval, the name of the Company will be changed to Elevra Lithium Limited (“Elevra Lithium”) upon completion of the Transaction. The Transaction will result in an approximate 50% / 50% equity holding of shareholders of Sayona and Piedmont Lithium (on a fully diluted basis) in Elevra Lithium immediately following the closing of the Transaction. Since the Transaction announcement, significant progress has been made in preparing for...

Continue reading

CMVC Acquires Orlando Medical Institute, Expanding Its Healthcare Education Portfolio with Paramedic and Emergency Medical Programs

Johanna Lanes, Robert Bonds, Felix Marquez, Abigial MarquezJohanna Lanes, COO. Robert Bonds, CEO. Felix Marquez, Founder. Abigail Marquez, Co-Founder.Real-World EMS Training at Orlando Medical InstituteStep into a real emergency scenario—right inside the classroom. At Orlando Medical Institute, students train in a fully immersive environment featuring a functional ambulance attached directly to the school. This hands-on simulation space is designed to replicate real-life emergency situations, equipping future EMTs and paramedics with the critical skills and confidence they need to respond under pressure. From patient transport to trauma care, OMI students experience every step of pre-hospital care in a setting that feels just like the real thing.OMI OfficesOrlando Medical Institute offers best-in-class facilities...

Continue reading

Creatd, Inc. to Acquire Air Charter Advisors in $3-$6 Million Stock Deal, Further Strengthening Its Aviation Portfolio Following the $8.3 Million Flyte Acquisition

Strategic Integration: Air Charter Advisors expands Flyte’s global reach while advancing revenues within its AI-enabled aviation platform Deal Terms: Valued between $3–6 million; expected to close within 60 daysNEW YORK, April 22, 2025 (GLOBE NEWSWIRE) — Creatd, Inc. (OTC: CRTD), a diversified holding company scaling growth through strategic acquisitions, has signed a Letter of Intent (“LOI”) to acquire Air Charter Advisors, Inc., a boutique private aviation firm based in Blue Bell, Pennsylvania. The transaction follows Creatd’s recent $8.3 million acquisition of Flyte (formerly Flewber Global, Inc.) and further solidifies its position as a leading consolidator of aviation assets. The deal will be executed through Flyte, Inc., a wholly owned subsidiary of Creatd, and is expected to close following the completion of due diligence...

Continue reading

Midland Announces the Acquisition of the Kan Gold Project in the Labrador Trough

Figure 1Midland Announces the Acquisition of the Kan Gold ProjectFigure 2Midland Announces the Acquisition of the Kan Gold ProjectFigure 3Midland Announces the Acquisition of the Kan Gold ProjectFigure 4Midland Announces the Acquisition of the Kan Gold ProjectFigure 5Midland Announces the Acquisition of the Kan Gold ProjectFigure 6Midland Announces the Acquisition of the Kan Gold ProjectFigure 7Midland Announces the Acquisition of the Kan Gold ProjectFigure 8Midland Announces the Acquisition of the Kan Gold ProjectFigure 9Midland Announces the Acquisition of the Kan Gold ProjectMONTREAL, April 22, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the acquisition of 100% interest in the Kan gold project...

Continue reading

ThermoFab Expands Capabilities with Acquisition of RIM Molding Assets

SHIRLEY, Mass., April 22, 2025 (GLOBE NEWSWIRE) — ThermoFab, a trusted leader in thermoforming and injection molding heavy gauge plastic enclosures and single use components for medical device and other critical highly regulated industries, is pleased to announce the acquisition of key Reaction Injection Molding (RIM) assets from Mearthane Products Corporation. All RIM components will be manufactured in ThermoFab’s USMCA-compliant Mexicali facility, allowing for efficient delivery throughout North America with no tariffs. This strategic investment significantly enhances ThermoFab’s capabilities, allowing us to better serve our customers with expanded RIM molding capacity, improved production efficiency, and greater flexibility in manufacturing complex, high-performance enclosures. The newly acquired assets include multiple custom-built...

Continue reading

FundThrough Acquires Ampla, Strengthening its Digital-First Invoice Funding Solution

The leading fintech funding platform for SMBs secures a $25M Series B equity investment, led by Klister Credit Corp.FundThrough Acquires Ampla, Strengthening its Digital-First Invoice Funding SolutionThe leading fintech funding platform for SMBs secures a $25M Series B equity investment, led by Klister Credit Corp.HOUSTON and TORONTO, April 22, 2025 (GLOBE NEWSWIRE) — FundThrough, the leading fintech invoice factoring platform for small and medium-sized businesses (SMBs), today announced its acquisition of Ampla, the leading provider of financial technology solutions for consumer brands offering working capital, business banking, corporate cards, and analytics. Ampla surpassed +$2B of loan originations and handled +$5T of transaction volume through its platform. This strategic acquisition strengthens FundThrough’s digital-first...

Continue reading

Barrick Announces Sale of Stake in Donlin Gold Project for Up To $1.1 Billion

All amounts expressed in US dollars TORONTO, April 22, 2025 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) (“Barrick”) today announced that it has reached an agreement to sell the 50 percent interest in the Donlin Gold Project in Alaska held by Barrick’s subsidiary Barrick Gold U.S. Inc. to affiliates of Paulson Advisers LLC (“Paulson”) and NOVAGOLD Resources Inc. (NYSE American, TSX:NG) for $1 billion in cash. In addition, Barrick has granted NOVAGOLD an option to purchase the outstanding debt owed to Barrick in connection with the Donlin Gold Project for $90 million if purchased prior to closing, or for $100 million if purchased within 18 months from closing, when the option expires. If that option is not exercised, the debt will remain outstanding, substantially in accordance with its existing terms. Paulson...

Continue reading

Form 8.3 – [ALLIANCE PHARMA PLC – 17 04 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ALLIANCE PHARMA PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

VitalSource Acquires RedShelf

Raleigh, NC, April 21, 2025 (GLOBE NEWSWIRE) — VitalSource announced today it has acquired RedShelf, the Chicago-based course materials distributor servicing hundreds of US higher education institutions. The acquisition expands VitalSource’s network of institutional and publisher partners, providing additional scale and talent to drive affordability and outcomes in a rapidly evolving landscape.   “We’re witnessing unprecedented change across higher education. Meeting the evolving needs of students, instructors, institutions, campus stores, and publishers requires deep investment only made possible by scale and stability,” said Kent Freeman, CEO of VitalSource. “We have long admired the RedShelf team, and we’re thrilled to combine efforts to deliver tomorrow’s technology to our shared partner network.”   The course materials market...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.